| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Priority Reports |
1 National Centre for Cell Science, Ganeshkhind, and 2 Jehangir Hospital and Medical Centre, Pune, India
Requests for reprints: Sharmila A. Bapat, National Centre for Cell Science, Lab 4, NCCS Complex, Ganeshkhind, Pune, Maharashtra 411007, India. Phone: 91-202-569-0922; Fax: 91-202-569-2259; E-mail: sabapat{at}nccs.res.in.
The cellular mechanisms underlying the increasing aggressiveness associated with ovarian cancer progression are poorly understood. Coupled with a lack of identification of specific markers that could aid early diagnoses, the disease becomes a major cause of cancer-related mortality in women. Here we present direct evidence that the aggressiveness of human ovarian cancer may be a result of transformation and dysfunction of stem cells in the ovary. A single tumorigenic clone was isolated among a mixed population of cells derived from the ascites of a patient with advanced ovarian cancer. During the course of the study, yet another clone underwent spontaneous transformation in culture, providing a model of disease progression. Both the transformed clones possess stem cell–like characteristics and differentiate to grow in an anchorage-independent manner in vitro as spheroids, although further maturation and tissue-specific differentiation was arrested. Significantly, tumors established from these clones in animal models are similar to those in the human disease in their histopathology and cell architecture. Furthermore, the tumorigenic clones, even on serial transplantation continue to establish tumors, thereby confirming their identity as tumor stem cells. These findings suggest that: (a) stem cell transformation can be the underlying cause of ovarian cancer and (b) continuing stochastic events of stem and progenitor cell transformation define the increasing aggression that is characteristically associated with the disease.
This article has been cited by other articles:
|
|
 |
|
  S. A. Hubbard, A. M. Friel, B. Kumar, L. Zhang, B. R. Rueda, and C. E. Gargett Evidence for Cancer Stem Cells in Human Endometrial Carcinoma Cancer Res., November 1, 2009; 69(21): 8241 - 8248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Bertolini, L. Roz, P. Perego, M. Tortoreto, E. Fontanella, L. Gatti, G. Pratesi, A. Fabbri, F. Andriani, S. Tinelli, et al. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment PNAS, September 22, 2009; 106(38): 16281 - 16286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Balch, F. Fang, D. E. Matei, T. H.-M. Huang, and K. P. Nephew Minireview: Epigenetic Changes in Ovarian Cancer Endocrinology, September 1, 2009; 150(9): 4003 - 4011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Hongling Du and H. S. Taylor Reviews: Stem Cells and Female Reproduction Reproductive Sciences, February 1, 2009; 16(2): 126 - 139. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Katz, K. Skorecki, and M. Tzukerman Niche-Dependent Tumorigenic Capacity of Malignant Ovarian Ascites-Derived Cancer Cell Subpopulations Clin. Cancer Res., January 1, 2009; 15(1): 70 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bussolati, S. Bruno, C. Grange, U. Ferrando, and G. Camussi Identification of a tumor-initiating stem cell population in human renal carcinomas FASEB J, October 1, 2008; 22(10): 3696 - 3705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Tilly and B. R. Rueda Stem Cell Contribution to Ovarian Development, Function, and Disease Endocrinology, September 1, 2008; 149(9): 4307 - 4311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Kaye Reversal of Drug Resistance in Ovarian Cancer: Where Do We Go From Here? J. Clin. Oncol., June 1, 2008; 26(16): 2616 - 2618. [Full Text] [PDF]
|
|
|
|
|
|
S. Zhang, C. Balch, M. W. Chan, H.-C. Lai, D. Matei, J. M. Schilder, P. S. Yan, T. H-M. Huang, and K. P. Nephew Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors Cancer Res., June 1, 2008; 68(11): 4311 - 4320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Li, X. Chen, T. Calhoun-Davis, K. Claypool, and D. G. Tang PC3 Human Prostate Carcinoma Cell Holoclones Contain Self-renewing Tumor-Initiating Cells Cancer Res., March 15, 2008; 68(6): 1820 - 1825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mimeault and S. K. Batra Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies Ann. Onc., October 1, 2007; 18(10): 1605 - 1619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Choi, A. S. T. Wong, H.-F. Huang, and P. C. K. Leung Gonadotropins and Ovarian Cancer Endocr. Rev., June 1, 2007; 28(4): 440 - 461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Gu, J. Yuan, M. Wills, and S. Kasper Prostate Cancer Cells with Stem Cell Characteristics Reconstitute the Original Human Tumor In vivo Cancer Res., May 15, 2007; 67(10): 4807 - 4815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wang, L.-P. Guo, L.-Z. Chen, Y.-X. Zeng, and S. H. Lu Identification of Cancer Stem Cell-Like Side Population Cells in Human Nasopharyngeal Carcinoma Cell Line Cancer Res., April 15, 2007; 67(8): 3716 - 3724. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
